New Paradigm Health Systems, Inc. Introduces Rapid Blood Alcohol Reduction Product

New Paradigm Health Systems, Inc.
announced plans today to market a new dietary supplement branded as
Sobrietol(R), which is designed to rapidly reduce blood alcohol.



When taken before, during or after alcohol consumption, Sobrietol(R)
accelerates elimination of blood alcohol. At the same time, harmful
metabolites are reduced. One of these metabolites is widely considered to
be the primary cause of hangover symptoms.



Statistics show that hangovers cost the American economy more than $148
billion each year in lost production; light to moderate drinkers account
for the majority of this loss. Even though over 40 products on the market
claim to reduce hangover effects, none are based on a patented technology
that brings down blood alcohol levels.



The technology was developed over a 10-year period. Continued research
using the patented technology was financially supported in part by the
National Institute of Alcohol Abuse and Alcoholism (NIAAA), one of the
National Institutes of Health (NIH). Dr. David Whitmire is the primary
inventor and a principal in New Paradigm Health Systems, Inc. The patent is
owned by and licensed from the University of Georgia Research Foundation.




Currently Sobrietol(R) is available only through the Company web site
(Sobrietol).



New Paradigm Health Systems, Inc., based in Seattle, WA, is a unique
producer of dietary supplements. New Paradigm Health Systems, Inc. is one
of very few companies seeking FDA approval for specific dietary supplements
to be used in conjunction with traditional treatments.


New Paradigm Health Systems, Inc.

Sobrietol